+143.3%
MRNA vs PHM
-4.6%
+147.9%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | PHM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.9% | -2.4% | -1.9% |
| 7D | -10.1% | -3.9% | -6.2% | -4.4% |
| 30D | +126.7% | -8.6% | +135.3% | +162.8% |
| 3M | +184.1% | -2.9% | +187.0% | +218.9% |
| 6M | +143.3% | -5.7% | +149.0% | +175.0% |
| All | +143.3% | -4.6% | +147.9% | +175.0% |
Cumulative growth
Daily Returns
Daily percentage return beside PHM.
Daily Out/Under-Performance
Portfolio return minus PHM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PHM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded PHM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling